Accolade, Inc. Stock Price, News & Analysis

Accolade (Nasdaq: ACCD) will showcase its Personalized Healthcare solutions at AHIP 2022 from June 21-23 in Las Vegas. The company aims to meet the needs of health plans seeking virtual-first care options. Key presentations include Dr. Shantanu Nundy discussing a post-pandemic framework for chronic care and Dr. Anupam Goel addressing virtual care for chronic diseases. Accolade emphasizes its partnership with Priority Health to enhance member engagement and satisfaction in Michigan by integrating virtual and in-person healthcare services.

Accolade, Inc. (NASDAQ: ACCD) will release its fiscal Q1 2023 financial results on June 30, 2022, after market close. A conference call is scheduled for 4:30 p.m. E.T. the same day to discuss the results. This healthcare provider serves over 600 employers, delivering personal and value-based healthcare solutions to millions of members. Accolade's services include virtual primary care and mental health support, consistently achieving consumer satisfaction ratings over 90%. For more details, visit ir.accolade.com.

Accolade, Inc. (NASDAQ: ACCD) has announced its participation in several upcoming investor conferences. The events include:

• June 8: Stifel 2022 Cross Sector Insight Conference at 4:10 pm ET in Boston
• June 9: 42nd Annual William Blair Growth Stock Conference at 3:00 pm ET in Chicago
• June 16: Goldman Sachs 43rd Annual Global Healthcare Conference at 12:20 pm ET in Rancho Palos Verdes, CA

Details and webcasts from these conferences will be available at ir.accolade.com.

Accolade, Inc. (NASDAQ: ACCD) announced its participation in two upcoming investor conferences. The first is on May 12 at 1pm ET at the BofA Securities 2022 Healthcare Conference in Las Vegas, and the second is on May 16 at 9:30am ET at the virtual 17th Annual Needham Technology & Media Conference. Accolade aims to enhance healthcare experiences through personalized, data-driven solutions, boasting consumer satisfaction ratings exceeding 90%. Webcasts will be available at ir.accolade.com for those interested.

Accolade (Nasdaq: ACCD) has launched Medication Integrated Care, a new solution aimed at helping employers tackle rising prescription drug costs and complications in medication management. With employer health plan costs climbing sharply, particularly a 7.4% increase in prescription drug spending in 2021, this service combines pharmacist-led medication therapy management with advanced analytics from Rx Savings Solutions. By identifying high-risk members, Medication Integrated Care aims to reduce both out-of-pocket expenses and hospital admissions, ultimately improving the overall healthcare experience for employees.

Accolade (Nasdaq: ACCD) appointed Jennifer Hanson as Chief Human Resources Officer and Executive Vice President of People and Culture as of May 2, 2022. She will oversee employee experience across eight global offices, enhancing engagement and professional growth. With over 20 years in healthcare HR, Hanson aims to attract and retain top talent in a growing employer healthcare market. CEO Rajeev Singh highlighted her innovation experience as vital for fostering a strong workplace culture amidst a transformative period for healthcare.

Accolade, Inc. (NASDAQ: ACCD) reported a 58% increase in fiscal Q4 2022 revenue, reaching $93.8 million compared to $59.2 million in Q4 2021. For the full fiscal year, revenue grew 82% to $310 million, up from $170.4 million. Despite strong growth, Accolade is moderating its top-line growth objectives due to a large client terminating its service relationship. The company reported a net loss of $34.6 million for Q4 and $123.1 million for the year. However, Cash reserves stand at $366 million, supporting future growth.

Accolade, Inc. (NASDAQ: ACCD) announced it will release its fiscal fourth quarter and full year 2022 financial results on April 28, 2022, after market close. A conference call will follow at 4:30 p.m. E.T. for detailed results discussion. Accolade is a healthcare provider serving over 600 employers and millions of members, focusing on personalized healthcare experiences. The company combines virtual primary care and intelligent technology to improve health outcomes and consumer satisfaction, maintaining ratings over 90%.

Priority Health has formed a strategic partnership with Accolade to enhance healthcare experiences for Michigan employers and their members. This collaboration aims to leverage virtual care and personalized navigation to drive employee engagement and reduce healthcare costs. Through their integrated approach, the two organizations will deliver unique health offerings that prioritize quality and value. This partnership aligns with Priority Health's growth objectives as the state's fastest-growing health plan, while Accolade focuses on empowering individuals to make informed healthcare decisions.